The short version
Medicare's cardiovascular indication is the single biggest expansion of GLP-1 coverage in US history. For patients post-MI, post-stroke or with established cardiovascular disease, Wegovy is now covered under Part D at a Medicare-determined copay (typically $50-$300 depending on plan). The catch: the prescription has to be coded for cardiovascular risk reduction, not for weight loss. Most general telehealth programs don't know how to do this. The programs below do.
What we considered
- Actively handles Medicare Part D billing (most telehealth programs are cash-pay only)
- Codes the prescription for cardiovascular indication, not weight loss
- Coordinates with the patient's cardiologist or primary care doctor
- Provides documentation of qualifying CV diagnosis
Top pick: Knownwell

Knownwell's full primary-care model integrates with Medicare Part D and codes prescriptions correctly for the cardiovascular indication. The strongest pick for a post-MI patient who needs Wegovy at the Medicare copay tier.
Read the full Knownwell review →
Other strong picks


